A pharmaceutical composition for prevention and treating airway inflammation, overproduction of mucin, and airway hypersensitiveness symptoms in respiratory inflammatory diseases

摘要

The present invention produced a plethora of airway inflammation , mucous membrane protein (mucin) of respiratory inflammation , and airway hypersensitivity symptoms relates to a pharmaceutical composition for the prevention and treatment , gamma - including compound as the active ingredient sikeuri hydratase reduce Th2 immune inflammation in respiratory diseases and increases the Th1 immunity , NF- B activation and goblet cells (goblet cell ) airway inflammation by inhibiting the production at the same time , airway hyperresponsiveness and byeongjan cell production as well as to inhibit the therapeutic effect gateul have utility as non-steroidal anti-inflammatory drugs (NSAID).